Precision Immuno-Oncology for Advanced Non-small Cell Lung Cancer Patients With PD-1 ICI Resistance (PIONeeR-BioMarkers (BM) Profiling)

NCT03493581 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

450

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer Patients

Interventions

PROCEDURE: BIOPSY
DIAGNOSTIC_TEST: blood-sampled
OTHER: feces samples

Sponsor

Assistance Publique Hopitaux De Marseille